Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.750
0.00 (0.00%)
At close: Jul 17, 2026, 4:00 PM EDT
1.770
+0.020 (1.14%)
After-hours: Jul 17, 2026, 6:58 PM EDT
Acrivon Therapeutics Employees
As of December 31, 2025, Acrivon Therapeutics had 76 total employees, including 74 full-time and 2 part-time employees. The number of employees decreased by 2 or -2.56% compared to the previous year.
Employees
76
Change (1Y)
-2
Growth (1Y)
-2.56%
Revenue / Employee
n/a
Profits / Employee
-$1,016,671
Market Cap
74.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 76 | -2 | -2.56% | 74 | 2 |
| Dec 31, 2024 | 78 | 17 | 27.87% | 75 | 3 |
| Dec 31, 2023 | 61 | 17 | 38.64% | 58 | 3 |
| Sep 30, 2023 | 59 | 17 | 40.48% | 56 | 3 |
| Jun 30, 2023 | 53 | 17 | 47.22% | 50 | 3 |
| Mar 31, 2023 | 48 | 12 | 33.33% | 45 | 3 |
| Dec 31, 2022 | 44 | - | - | 41 | 3 |
| Sep 30, 2022 | 42 | - | - | 39 | 3 |
| Jun 30, 2022 | 36 | - | - | 35 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| Biomea Fusion | 40 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| LeonaBio | 19 |
| Cognition Therapeutics | 14 |
ACRV News
- 4 weeks ago - Acrivon Therapeutics assumed with an Outperform at Oppenheimer - TheFly
- 7 weeks ago - Acrivon Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 2 months ago - Acrivon Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Acrivon Therapeutics to Present at TD Cowen's 7th Annual Oncology Innovation Summit - GlobeNewsWire
- 2 months ago - Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Acrivon Therapeutics reports Q1 EPS (49c), consensus (52c) - TheFly
- 2 months ago - Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts - GlobeNewsWire
- 2 months ago - Acrivon Therapeutics Earnings release: Q1 2026 - Filings